0 Bewertungen

ID

32535

Beschreibung

Study ID: 109059 Clinical Study ID: OTB109059 Study Title: TXA107979:A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men with Premature Ejaculation Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01021553 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: epelsiban Trade Name: Study Indication: Premature Ejaculation

Stichworte

  1. 06.11.18 06.11.18 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

6. November 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    Delay in IELT, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK557296 in Men with Premature Ejaculation, 109059

    Concomitant Medications

    Concomitant Medications
    Beschreibung

    Concomitant Medications

    Alias
    UMLS CUI-1
    C2347852 (Concomitant Agent)
    Sequence Number
    Beschreibung

    Concomitant Agent, Sequence Number

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C2348184 (Sequence Number)
    Drug Name
    Beschreibung

    Concomitant Agent, Medication Name

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C2360065 (Medication name)
    LOINC
    MTHU027854
    Unit Dose
    Beschreibung

    Concomitant Agent, Dosage

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C0178602 (Dosage)
    SNOMED
    260911001
    LOINC
    LP7180-5
    Units
    Beschreibung

    Concomitant Agent, Unit of Measure

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C1519795 (Unit of Measure)
    SNOMED
    767524001
    Frequency
    Beschreibung

    Concomitant Agent, Frequencies

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C0439603 (Frequencies (time pattern))
    SNOMED
    272123002
    LOINC
    LP130485-8
    Route
    Beschreibung

    Concomitant Agent, Drug Administration Routes

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C0013153 (Drug Administration Routes)
    SNOMED
    410675002
    LOINC
    LP40261-7
    Reason for Medication
    Beschreibung

    Concomitant Agent Use Indication

    Datentyp

    text

    Alias
    UMLS CUI [1]
    C2826696 (Concomitant Medication Use Indication)
    Start Date and Time
    Beschreibung

    Concomitant Agent, Start Date, Start time

    Datentyp

    datetime

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C0808070 (Start Date)
    UMLS CUI [1,3]
    C1301880 (Start time)
    SNOMED
    398201009
    LOINC
    LP102339-1
    Taken Prior to Study ?
    Beschreibung

    Concomitant Agent, Before, Clinical Trial Period

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C0332152 (Before)
    SNOMED
    236874000
    UMLS CUI [1,3]
    C2347804 (Clinical Trial Period)
    Ongoing?
    Beschreibung

    Concomitant Medication ongoing

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C2826666 (Concomitant Medication Ongoing)
    Concomitant Agent, End Date, End time
    Beschreibung

    Concomitant Agent, End Date, End time

    Datentyp

    datetime

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C0806020 (End date)
    SNOMED
    454551000124105
    LOINC
    MTHU008302
    UMLS CUI [1,3]
    C1522314 (End Time)
    SNOMED
    397898000

    Ähnliche Modelle

    Concomitant Medications

    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    Concomitant Medications
    C2347852 (UMLS CUI-1)
    Concomitant Agent, Sequence Number
    Item
    Sequence Number
    integer
    C2347852 (UMLS CUI [1,1])
    C2348184 (UMLS CUI [1,2])
    Concomitant Agent, Medication Name
    Item
    Drug Name
    text
    C2347852 (UMLS CUI [1,1])
    C2360065 (UMLS CUI [1,2])
    Concomitant Agent, Dosage
    Item
    Unit Dose
    text
    C2347852 (UMLS CUI [1,1])
    C0178602 (UMLS CUI [1,2])
    Concomitant Agent, Unit of Measure
    Item
    Units
    text
    C2347852 (UMLS CUI [1,1])
    C1519795 (UMLS CUI [1,2])
    Concomitant Agent, Frequencies
    Item
    Frequency
    text
    C2347852 (UMLS CUI [1,1])
    C0439603 (UMLS CUI [1,2])
    Concomitant Agent, Drug Administration Routes
    Item
    Route
    text
    C2347852 (UMLS CUI [1,1])
    C0013153 (UMLS CUI [1,2])
    Concomitant Agent Use Indication
    Item
    Reason for Medication
    text
    C2826696 (UMLS CUI [1])
    Concomitant Agent, Start Date, Start time
    Item
    Start Date and Time
    datetime
    C2347852 (UMLS CUI [1,1])
    C0808070 (UMLS CUI [1,2])
    C1301880 (UMLS CUI [1,3])
    Concomitant Agent, Before, Clinical Trial Period
    Item
    Taken Prior to Study ?
    boolean
    C2347852 (UMLS CUI [1,1])
    C0332152 (UMLS CUI [1,2])
    C2347804 (UMLS CUI [1,3])
    Concomitant Medication ongoing
    Item
    Ongoing?
    boolean
    C2826666 (UMLS CUI [1])
    Concomitant Agent, End Date, End time
    Item
    datetime
    C2347852 (UMLS CUI [1,1])
    C0806020 (UMLS CUI [1,2])
    C1522314 (UMLS CUI [1,3])

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video